Document is current
Any future updates will be listed below
-
Authors
Gehin, Johanna Elin https://orcid.org/0000-0002-9896-0223
Goll, Guro Løvik https://orcid.org/0000-0002-8506-725X
Brun, Marthe Kirkesæther https://orcid.org/0000-0001-5148-9684
Jani, Meghna https://orcid.org/0000-0002-1487-277X
Bolstad, Nils https://orcid.org/0000-0003-3633-8428
Syversen, Silje Watterdal https://orcid.org/0000-0003-2159-3696
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Accepted: 26 September 2022
First Online: 31 October 2022
Declarations
:
: Open access funding provided by University of Oslo (including Oslo University Hospital). MJ is funded by a National Institute for Health Research (NIHR) Advanced Fellowship [NIHR301413]. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, National Health Service or the UK Department of Health and Social Care. SWS, MKB, and GLG are funded by grants from the Norwegian South-Eastern Regional Health Authorities.
: GLG has received honoraria, consulting fees, and payment for lectures from Pfizer, AbbVie, Boehringer Ingelheim, Roche, Orion Pharma, Sandoz, Novartis, and UCB, all unrelated to the present work. JEG, MKB, MJ, NB, and SWS report no relevant disclosures.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: JEG: Review design; drafting and revision manuscript; preparation of figures. GLG: review design; drafting and revision of manuscript. MKB: Drafting and revision of manuscript. MJ: Drafting and revision of manuscript. NB: Review design; drafting and revision of manuscript. SWS: Review design; drafting and revision of manuscript.
